Your browser doesn't support javascript.
loading
Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial.
Sanchorawala, Vaishali; Brauneis, Dina; Shelton, Anthony C; Lo, Stephen; Sun, Fangui; Sloan, J Mark; Quillen, Karen; Seldin, David C.
Affiliation
  • Sanchorawala V; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts. Electronic address: vaishali.sanchorawala@bmc.org.
  • Brauneis D; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.
  • Shelton AC; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.
  • Lo S; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.
  • Sun F; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
  • Sloan JM; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.
  • Quillen K; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.
  • Seldin DC; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts.
Biol Blood Marrow Transplant ; 21(8): 1445-51, 2015 Aug.
Article in En | MEDLINE | ID: mdl-25858810

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Induction Chemotherapy / Bortezomib / Amyloidosis / Melphalan / Antineoplastic Agents Type of study: Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2015 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Transplantation Conditioning / Induction Chemotherapy / Bortezomib / Amyloidosis / Melphalan / Antineoplastic Agents Type of study: Observational_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Biol Blood Marrow Transplant Journal subject: HEMATOLOGIA / TRANSPLANTE Year: 2015 Document type: Article